Identification
- Composition (DCI)
- dantrolène
- Manufacturer
- SUN PHARMACEUTICALS NORTH AFRICA S.A
- ATC code
- M03CA01
- Presentation
- Boite de 30
- Schedule / Reimb.
- A
- Hospital price
- 25.60 MAD
Indications
Traitement des formes chroniques et sévères de spasticité des muscles squelettiques résultant de troubles tels que les accidents vasculaires cérébraux, les lésions de la moelle épinière, la paralysie cérébrale et la sclérose en plaques chez l’adulte et chez l’enfant de plus de 5 ans pesant 25 kg ou plus.
Find an open pharmacy
On-call pharmacies near you
About DARELAX 25 MG
DARELAX 25 MG is marketed in Morocco by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of DARELAX 25 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about DARELAX 25 MG
Answers to common questions from Moroccan patients about this drug.